Switching biologicals: switching TNFalpha antagonists in psoriasis treatment.
Schmitt-Egenolf
Marcus
M
D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha